Business Context and Reporting Period
Company: Key Tronic Corporation (KeyTronicEMS)
Filing Type: Form 10-K (Annual Report)
Period Ended: June 28, 2003
Business Overview: The Company provides electronic manufacturing services (EMS) for original equipment manufacturers (OEMs) and manufactures keyboards. Operations are conducted in the U.S., Mexico, China, and Ireland. EMS services accounted for 88.6% of revenues in fiscal 2003, while keyboard sales declined to 11.1%.
Key Financial Metrics
| Metric | Fiscal 2003 | Fiscal 2002 | Fiscal 2001 |
|---|---|---|---|
| Net Sales | $130.9 million | $175.6 million | $165.9 million |
| Gross Profit | $15.0 million | $15.0 million | $7.6 million |
| Gross Margin | 11.4% | 8.5% | 4.6% |
| Operating Income | $2.6 million | $1.2 million | $(9.5) million |
| Net Income (Loss) | $13.4 million | $(25.4) million | $(11.4) million |
| Diluted EPS | $1.39 | $(2.62) | $(1.18) |
| Cash from Operations | $(0.5) million | $0.9 million | $7.5 million |
| Total Assets | $59.1 million | $57.4 million | $74.4 million |
| Long-Term Debt | $9.9 million | $6.5 million | N/A |
| Working Capital | $21.8 million | $22.3 million | $22.9 million |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 25% to $130.9 million, driven by a 26% drop in EMS sales and a 20% drop in keyboard sales. This was attributed to a slowdown in shipments to major customers and the lingering effects of litigation uncertainty.
- Profitability Surge: Despite lower sales, the Company reported a net income of $13.4 million compared to a $25.4 million loss in 2002. This turnaround was primarily due to a one-time benefit of $12.2 million from the reversal of a previously recorded litigation accrual following a settlement.
- Margin Improvement: Gross margin improved to 11.4% from 8.5% due to operating efficiencies and lower material costs.
- Customer Concentration: Clorox accounted for 31% of revenue (down from 39% in 2002). The top five customers accounted for 63% of total sales, down from 76% in 2002.
- Debt Increase: Revolving credit facility borrowings increased to $9.9 million from $6.5 million to fund litigation settlement payments and inventory ramp-ups.
Guidance, Outlook, Risks, and Unusual Items
- Unusual Items: The fiscal 2003 results were significantly impacted by the settlement of the F&G Scrolling Mouse litigation. The Company recorded a $12.2 million benefit from the reversal of an accrual. The settlement requires payments totaling $7.0 million, with $3.3 million paid in fiscal 2003 and remaining payments due through 2005.
- Outlook: Management expects an increase in new business as the uncertainty surrounding the litigation has been resolved. The Company anticipates expanding its EMS business, particularly in Europe, though current European sales remain primarily focused on keyboards.
- Risks:
- Customer Concentration: Heavy reliance on a few major customers (Clorox, HP, Lexmark) creates vulnerability to order cancellations or delays.
- Competition: The EMS industry is intensely competitive with pressure on pricing and margins.
- Supplier Dependence: Reliance on sole-source suppliers for key components poses supply chain risks.
- Foreign Operations: Significant manufacturing in Mexico and China exposes the Company to international regulatory and economic risks.
- Liquidity: The Company maintains a $25 million revolving credit facility with approximately $3.0 million available as of June 28, 2003. Management believes internal funds and the credit facility are sufficient to meet obligations for over 12 months.
Investor Verification Checklist
- Litigation Settlement Terms: Verify the remaining payment schedule for the $7.0 million F&G settlement and the potential for penalties if payments are missed.
- Customer Retention: Assess the stability of the top five customers, particularly Clorox (31% of sales), given the lack of long-term volume contracts.
- Inventory Levels: Review the $5.8 million increase in inventory ($24.2 million total) to ensure it aligns with confirmed future orders and does not indicate obsolescence risks.
- Debt Covenants: Confirm continued compliance with the CIT Group financing agreement covenants regarding equity, EBITDA, and fixed charge ratios.
- Recurring Earnings: Analyze operating income excluding the one-time litigation benefit to understand the core operational profitability trend.